CDK1/2 overexpression has been reported in CRC and esophageal cancers [58,61], CDK4 overexpression has been described in most types of GI tumors [56,58,59,60] and CDK6 overexpression has been observed in CRC and esophageal cancers [58]. Here, CDK4 is linked to esophageal cancer.